AlphAIAlphAI — Financial news for AI agents
news.bloomberglaw.comSEP 182 min read$NKE

Nike Drops Sports Watch Patent Suit After PTAB Loss to Lululemon

Nike Inc. dropped its lawsuit against Lululemon USA Inc. after the Federal Circuit upheld a ruling that the patent in question was invalid. The case involved Nike's claim that Lululemon's Mirror Home Gym infringed on its patents, but Lululemon successfully challenged the patent's validity.

Original reporting
news.bloomberglaw.com
Published Sep 18, 2026, 6:52 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Sep 18, 2026, 7:44 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
About AlphAI AI DeskScoring methodologyReport an issue
Nike Drops Sports Watch Patent Suit After PTAB Loss to Lululemon — source image
Source · news.bloomberglaw.com
Decision brief

The 30-second read

$NKEBullishMed
01

Why it matters

Removal of litigation risk could improve investor sentiment for both firms.

02

Market read

Legal resolution may lead to modest price adjustments for the involved companies.

03

What to watch

Potential future patent challenges from other competitors.

Relevance 6/10Novelty 7/10Timing: today

Background

Nike had sued Lululemon over a sports watch patent tied to its Mirror Home Gym product. The PTAB and Federal Circuit invalidated the patent.

Company-level read

Ticker impact

$NKEBullishMedium confidence
Context

Nike voluntarily dismissed its patent lawsuit against Lululemon after PTAB invalidated the patent.

Expected impact

Modest price increase expected in the near term.

Evidence & confidence

Legal dismissal reduces uncertainty; market may price in lower risk premium.

$LULUBullishMedium confidence
Context

Lululemon successfully defended the patent, leading Nike to drop its suit.

Expected impact

Minor positive price pressure.

Evidence & confidence

Victory reinforces product roadmap and reduces legal expense exposure.

Market effects

Sector

Patent litigation risk in apparel tech sector is highlighted.

Regional

U.S. consumer apparel stocks may see slight re‑rating.

Global

Limited to companies with similar wearable tech patents.

Counterpoint

What could challenge this read

Legal outcomes may not materially affect earnings; price reaction could be muted.

Key entities

  • Company
    Nike Inc.

    Shoes and apparel maker, plaintiff in the patent suit.

  • Company
    Lululemon USA Inc.

    Athletic apparel company, defendant in the patent suit.

Read at source← All news

Related articles

SEP 26
$NKEHigh

EXEC: Nike Faces Downgrade From Bank of America

Bank of America downgraded Nike (NKE) due to slower-than-expected turnaround, cutting EPS estimates and price target to $30. Analyst cites weak sales growth, pressure on classics, and macro challenges. Nike shares closed at $35.75. The analyst expects North American wholesale sales to decline from Q2 FY27 and sees risks in China due to distribution changes.

sgbonline.com2 min
SEP 26
$NKEMed

Nike Stock (NKE) Opinions on BofA Securities Downgrade

BofA Securities downgraded Nike (NKE) to Underperform, citing sales declines and competitive pressures. Analysts noted China revenue weakness and margin pressures. Insiders and hedge funds have recently traded NKE shares, with mixed signals. Q4 2026 revenue was $11B, down 1.13% YoY. Analysts' price targets range from $23 to $75.

quiverquant.com2 min
SEP 26
$NKEHigh

Bank of America Downgrades Nike (NKE) Amid Prolonged Turnaround,

Bank of America downgraded Nike (NKE) to Underperform, lowering its price target to $30 from $47. The firm cited slower-than-expected turnaround, cutting fiscal 2027 and 2028 EPS estimates by 11% and 12%. Concerns include negative sales growth and inventory-demand imbalances in North America. Nike's dividend yield is 4.59%, but its payout ratio is 72%, raising sustainability questions.

gurufocus.com2 min
SEP 26
$GENIMed

Genius, CF, 3M, Nike, Synopsys Trending With Analysts

Analysts cover five stocks: Genius Sports (GENI) with a $8 target, CF Industries (CF) with a $162 target, 3M (MMM) upgraded to Hold with a $171 target, Nike (NKE) downgraded to Sell with a $30 target, and Synopsys (SNPS) upgraded to Buy with a $700 target. Analysts cite growth, valuation, and market conditions as key factors.

tipranks.com2 min
SEP 25
$NKEMed

Nike stock still hasn't bottomed, analyst warns

Bank of America analyst Lorraine Hutchinson downgraded Nike (NKE) to underperform, setting a $30 price target, 15% below current levels. She cites prolonged revenue weakness, Greater China sales decline, and wholesale inventory risks. Nike's stock is down 45% year-to-date. Hutchinson also lowered EPS estimates for 2027 and 2028, raising concerns about dividend durability with a 107% payout ratio projected for 2027.

invezz.com2 min